Anti-SHC 抗体 [EP332Y]
Anti-SHC antibody [EP332Y]
- RabMAb
- Recombinant
- KO Validated
- 詳細を見る
Be the first to review this product! Submit a review
|
(19 Publications)
Rabbit Recombinant Monoclonal SHC antibody. Suitable for IHC-P, WB and reacts with Human, Rat, Mouse samples. Cited in 19 publications.
別名を表示する
SHC, SHCA, SHC1, SHC-transforming protein 1, SHC-transforming protein 3, SHC-transforming protein A, Src homology 2 domain-containing-transforming protein C1, SH2 domain protein C1
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SHC antibody [EP332Y] (AB33770)
ab33770 staining SHC in Human stomach tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed and paraffin-embedded, antigen retrieval was by heat mediation in Tris/EDTA buffer pH9. Samples were incubated with primary antibody (1/300). An undiluted HRP-conjugated mouse anti-rabbit IgG was used as the secondary antibody. Tissue counterstained with Hematoxylin. PBS was used in the negative control rather than the Primary antibody.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-SHC antibody [EP332Y] (AB33770)
ab33770 staining SHC in Human renal carcinoma tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed and paraffin-embedded, antigen retrieval was by heat mediation in Tris/EDTA buffer pH9. Samples were incubated with primary antibody (1/300). An undiluted HRP-conjugated mouse anti-rabbit IgG was used as the secondary antibody. Tissue counterstained with Hematoxylin. PBS was used in the negative control rather than the Primary antibody.
- WB
Supplier Data
Western blot - Anti-SHC antibody [EP332Y] (AB33770)
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Western blot - Anti-SHC antibody [EP332Y] (ab33770) at 1/1000 dilution
Lane 1:
MCF-7 cell lysate at 20 µg
Lane 2:
HeLa cell lysate at 20 µg
Lane 3:
Jurkat cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), HRP-conjugated at 1/1000 dilution
Predicted band size: 62 kDa
false
- WB
Lab
Western blot - Anti-SHC antibody [EP332Y] (AB33770)
Western blot : Anti-SHC antibody [EP332Y] ab33770 staining at 1/1000 dilution, shown in green; Mouse anti GAPDH ab8245 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 50, 55, 100-140 kDa in Wild-type A549 cell lysates with no signal observed at this size in SHC1 knockout A549 cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-SHC antibody [EP332Y] (ab33770) at 1/1000 dilution
Lane 1:
Wild-type A549 at 20 µg
Lane 2:
SHC1 knockout A549 at 20 µg
Lane 3:
HT1080 at 20 µg
Lane 4:
Raji at 20 µg
Lane 5:
HL-60 at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 100-140 kDa
Observed band size: 55 kDa,50 kDa,63 kDa,37 kDa
false
- WB
Unknown
Western blot - Anti-SHC antibody [EP332Y] (AB33770)
All lanes:
Western blot - Anti-SHC antibody [EP332Y] (ab33770) at 1/2000 dilution
All lanes:
MCF 7 cell lysate
Predicted band size: 62 kDa
Observed band size: 46 kDa,52 kDa,66 kDa
false
- WB
Supplier Data
Western blot - Anti-SHC antibody [EP332Y] (AB33770)
Blocking buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM /TBST.
All lanes:
Western blot - Anti-SHC antibody [EP332Y] (ab33770) at 1/1000 dilution
Lane 1:
C6 Cell lysate at 20 µg
Lane 2:
RAW264.7 Cell lysate at 20 µg
Lane 3:
NIH/3T3 Cell lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG, (H+L), HRP-conjugated at 1/1000 dilution
Predicted band size: 62 kDa
false
関連する標識済み抗体及び組成の異なる製品 (1)
-
Anti-SHC antibody [EP332Y] - BSA and Azide free
Reactivity data
製品の詳細
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
出荷温度及び保存条件
製品の状態
精製方法
バッファー組成
出荷温度
短期保存温度
長期保存温度
分注に関する情報
保管に関する情報
補足情報
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The SHC protein transmits signals from cell surface receptors to downstream effectors. It does so by linking activated receptors to the Ras-MAPK signaling cascade. SHC often part of larger protein complexes interacts with proteins such as Grb2 and SOS to relay signals necessary for cell growth and differentiation. This interaction leads to the activation of Ras and subsequent mitogen-activated protein kinase pathways influencing various cellular responses.
Pathways
SHC is a central component of the MAPK/ERK and PI3K/AKT pathways which are important for cell growth and survival. In these pathways SHC mediates signals from receptor tyrosine kinases like the epidermal growth factor receptor (EGFR). By interacting with EGFR and other receptors SHC helps propagate signals essential for cellular proliferation and survival. SHC associates with proteins like Grb2 and SOS linking RTKs to the Ras signaling cascade.
製品プロトコール
- Visit the General protocols
- Visit the Troubleshooting
ターゲットの情報
文献 (19)
Recent publications for all applications. Explore the full list and refine your search
iScience 27:110846 PubMed39310759
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:20150 PubMed39209911
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 22:489 PubMed39143532
2024
Applications
Unspecified application
Species
Unspecified reactive species
Redox report : communications in free radical research 29:2324234 PubMed38444386
2024
Applications
Unspecified application
Species
Unspecified reactive species
World journal of diabetes 14:1249-1258 PubMed37664479
2023
Applications
Unspecified application
Species
Unspecified reactive species
The FEBS journal 290:4562-4576 PubMed37255287
2023
Applications
Unspecified application
Species
Unspecified reactive species
Medicine and science in sports and exercise 55:1770-1780 PubMed37144632
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 13:1035755 PubMed36686673
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular gastroenterology and hepatology 15:197-211 PubMed36122677
2022
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:951 PubMed34335893
2021
Applications
Unspecified application
Species
Unspecified reactive species
Abcam product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com